PDGFRα: Expression and Function during Mitral Valve Morphogenesis

Area of Science:

• Cardiovascular Biology
• Developmental Biology
• Cell Signaling

Background:

• Mitral valve prolapse (MVP) is a common valvular heart disease with potential severe complications.
• Recent findings link MVP to mutations in primary cilia genes, suggesting a role for cilia in disease development.

Purpose of the Study:

• To investigate the role of platelet-derived growth factor receptor-alpha (PDGFRα) in heart valve development.
• To elucidate the mechanisms by which PDGFRα influences valve structure and function.

Main Methods:

• Utilized genetically modified mice with conditional Pdgfra ablation.
• Employed biochemical assays and high-resolution microscopy for detailed analysis.
• Conducted in vitro cell culture experiments to assess signaling pathways.

Main Results:

• PDGFRα expression is dynamic during valve development, initially widespread and later restricted to the endocardium.
• Conditional Pdgfra ablation resulted in enlarged, hypercellular valve leaflets with disrupted endothelial integrity and altered extracellular matrix.
• In vitro studies showed PDGFRα suppresses ERK1/2 activation and promotes AKT phosphorylation.

Conclusions:

• PDGFRα is crucial for stabilizing the valve endocardium during development.
• PDGFRα acts through an AKT/ERK signaling pathway to prevent mesenchymal transformation and mitigate disease phenotypes.
• These findings identify PDGFRα as a key regulator in preventing mitral valve prolapse-related pathologies.